A major hallmark of cancer is uncontrolled growth on soft matrices, i.e. transformed growth.
Introduction
For normal cell growth, complex cellular mechanical functions sense the microenvironment. When cells encounter the wrong environment, the output from these sensing events will block growth.
Matrix rigidity is an important aspect of the microenvironment for normal development and regeneration, whereas cancer cells ignore rigidity and grow on very soft surfaces. This is the basis for the soft agar assay, which is a standard test for the malignancy level of cancers (1). We recently described the rigidity sensing apparatus as a cytoskeletal protein complex that contracts matrix to a fixed distance; if the force generated by this contraction exceeds about 25 pN, the matrix will be considered rigid (2) . This is just one of a number of modular machines that perform important tasks in cells similar to the clathrin-dependent endocytosis complex (3) . Such machines typically assemble rapidly from mobile components, perform the desired task and disassemble in a matter of seconds to minutes. They are activated by one set of signals and are designed to generate another set of signals. The cell rigidity sensing complex is a 2-3 µm-sized modular machine that forms at the cell periphery during early contact with matrix (2, (4) (5) (6) (7) . It is powered by sarcomerelike contractile units (CUs) that contain myosin-IIA, actin filaments, tropomyosin 2.1 (Tpm 2.1), -actinin 4, and other cytoskeletal proteins (7) . The number of CUs depends upon EGFR or HER2 activity as well as substrate rigidity (6) . Further, the correct length and duration of contractions are controlled by receptor tyrosine kinases through interactions with cytoskeletal proteins (5) . CUs are activated in spreading cells; and on rigid surfaces, they stimulate the formation of mature adhesions. However, on soft surfaces, contractions are very short-lived and adhesions rapidly disassemble, leading to cell death by anoikis (2, 7) . Since cancer cells fail to activate anoikis pathways on soft matrices, we hypothesize that rigidity-sensing CUs can block growth on soft surfaces and their depletion in cancer cells can enable growth on soft agar. Cytoskeletal proteins are highly integrated and their functions are well studied in normal cells (8) .
However, the role of cytoskeletal components in cell transformation and cancer metastasis development is still not clear. Mutations and abnormal expression of various cytoskeletal or cytoskeletal-associated proteins have been reported in many cancer studies (9) : Myosin IIA has been identified as a tumor suppressor of squamous cell carcinomas (10) ; The expression level of Tpm 2.1, one isoform from the tropomyosin family, is highly suppressed in a variety of cancer cell lines (11) ; Tpm 3, another tropomyosin isoform, has been reported to be the predominant tropomyosin in primary tumors and tumor cell lines (12) . Interestingly, in studies using arrays of elastic PDMS pillars, depletion of Tpm 2.1 in normal MCF 10A cells caused transformation as well as disruption of CU formation, while restoration of normal levels of Tpm 2.1 in metastatic MDA-MB-231 cells blocked transformed growth on soft agar (2, 11) . Further, removing another CU component, α-actinin 4, in mouse embryonic fibroblast (MEF) cells enabled rapid growth on soft matrices (7). These findings indicated that unbalanced expression levels of different cytoskeletal proteins correlates with cell transformation. Here we extend those findings to show that widely different cancer lines do not have rigidity-sensing contractions and that modifications of cytoskeletal protein levels can restore contractions along with the activation of apoptosis on soft surfaces.
Results:
Transformed cells lack rigidity sensing activity due to altered levels of contractile unit (CU) components.
To examine the relationship between rigidity sensing CU formation and transformed growth, we examined four different cancer lines and a transformed cell line, each randomly selected from a different tissue. The bases of transformation are listed for each line in Table 1 : 1) Cos7 cells were derived from African green monkey kidney fibroblast cells by SV40 transformation; 2) MDA-MB-231 human breast cancer line formed tumors in nude mice (13, 14) ; 3) HT1080, a fibrosarcoma line from an untreated patient that carried an IDH1 mutation (15); 4) SKOV3 a human ovarian adenocarcinoma line with an epithelial-like morphology (16); 5) LLC, a lung carcinoma line from a C57BL mouse (17) . Human foreskin fibroblast (HFF) cells served as the non-transformed control. CU activity was measured by a previously described method (6) that involved spreading cells on arrays of elastic pillars (0.5 µm diameter) and automated analyses of the pillar displacements (see displacements of two nearby pillars toward each other (a CU) at the cell periphery in Supplementary Figure 1) . Consistent with previous publications, HFF cells generated 145±14.3 CUs on rigid pillars (k=8.4 pN/nm) and 66±3.7 CUs on soft pillars (k=1.6 pN/nm) per 10 minutes during the first 30 minutes of spreading. In contrast, all the transformed cells produced no or few CUs (less than 10) on the two pillar types during early spreading ( Figure   1 A and B) . To test whether cells were able to distinguish between rigid and soft surfaces at a later spreading stage, we plated the 6 different cell lines on stiff (2MPa) and compliant (5kPa) fibronectin-coated PDMS surfaces for 6 hours. Cells were then fixed and stained with paxillin and actin as markers for adhesion formation and morphology change, respectively (Figure 1 C). As previously described (18) , HFF cells polarized on rigid PDMS and spread less on soft PDMS in a round shape. However, all the five transformed cell lines showed no significant difference in cell polarization level or adhesion size on the surfaces with a 400-fold difference in rigidity ( Figure 1 D and E). Since transformation was defined classically as growth on soft agar (1), we cultured the different cell lines in soft agar for 7 days. All five transformed cell lines formed colonies while HFF cells barely survived ( Figure 1 F and G) . Thus, none of the transformed lines developed a significant number of CUs for rigidity sensing. This was consistent with the inability of those lines to react to differences in matrix rigidity and to grow on soft surfaces.
Why did the transformed cells lines lack rigidity sensing activity? To answer this question, we performed western blot analyses of the known CU proteins (Figure 2 To address these questions we first tested whether we could block transformed growth by simply restoring the missing CU components for rigidity sensing. We selected Cos7 cells, which lacked myosin IIA, as the first candidate. After expression of EGFP-myosin IIA, Cos7 cells generated Supplementary figure 7) . Thus, high levels of Tpm 3 inhibited cell rigidity sensing CU formation by competing with endogenous Tpm 2.1 in normal fibroblasts.
Discussion
Based upon the current and related findings, transformation follows upon the unbalanced expression of different cytoskeletal proteins that decreases rigidity sensing contractile unit (CU) formation in all tested cell lines. In many different cell backgrounds, CUs are needed for rigiditydependent growth, i.e., growth on rigid surfaces and activation of Caspase-3-dependent anoikis on soft matrices. In the initial characterization of CUs, the major cytoskeletal components, Tpm 2.1, myosin-IIA, and α-actinin 4, are necessary components for CU formation (2, 7) . In these studies, overexpression of another cytoskeletal protein, Tpm 3, causes CU disruption. Interestingly, all of these components are either tumor suppressors (Tpm 2.1, Myosin IIA and a-actinin 4) or tumor promoters (Tpm 3). From previous studies, Tpm 2.1 is down-regulated in a wide variety of transformed cell lines (20) (21) (22) (23) . Overexpression of miR-21, a microRNA that targets the Tpm 2.1 RNA (24) , is observed in breast tumors and correlates with the severity of the disease (25) . Further, reduction of miR-21 induces glioma cell apoptosis through Caspase pathways (26) . In an in vivo RNAi screen, myosin-IIA has been identified as a tumor suppressor of squamous cell carcinomas (10) . -actinin 4, as well, has been recognized as a tumor suppressor in cases of neuroblastoma and lung cancers (27, 28) . In contrast, Tpm 3 is responsible for metastatic melanoma motility regulation (29) and expression levels are elevated in many different cancer lines (12) . Thus, cancer cells that are characterized by transformed growth on soft surfaces, have altered levels of various cytoskeletal proteins that correlate with the loss of local CUs involved in rigidity sensing.
One of the major pathways to induce transformation is to express mutant Ras, which is normally activated by a variety of RTKs that participate in cell proliferation, transformation, and regulation of differentiation (30) . An additional connection between cancer and the local CUs comes from the role that tyrosine kinases play in rigidity sensing. Previous studies show that rigidity sensing requires the action of the Src family kinases (SFKs). Knocking out the upstream activator, RPTP, or the three Src kinases, Src, Yes, and Fyn (SYF cells) blocks the ability of those cells to sense substrate rigidity and also enables growth on soft surfaces (34, 35) . This is consistent with our recent study that showed that ErbB family members (EGFR and HER2) are recruited to adhesion sites by SFKs on rigid surfaces and are needed for formation of CUs in early cell spreading (6) . These findings indicate that RTKs involved in cancer and EMT also play important roles in rigidity sensing regulation.
It is clear from many different studies that transformed cell growth is insufficient for metastasis and extensive cancer growth. However, the faulty mechanosensing machinery in transformed cells enables them to escape from the apoptosis pathways and to survive in many different environments, which is important for metastasis. Re-introduction of the missing CU components in transformed cell lines successfully rebuilds the rigidity sensing process in many different cell backgrounds. Restoring the ability to correctly sense rigidity causes transformed cells to die on soft surfaces without further manipulations. This provides a different view of blocking transformed growth. Namely, a functional rigidity sensor activates apoptosis pathways on soft surfaces and the depletion of those sensors is often sufficient for cell growth. Although there may be other mechanisms for causing growth on compliant matrices, the loss of the rigidity-sensing modules is a robust mechanism. As modular sensory units in self-driving cars are needed to stop them when an object is in their path, the modular rigidity-sensing units are needed for cells to know when the matrix is soft and growth should stop. The observation that depleting various components of rigidity-sensing modules depletes rigidity-sensing indicates that like many complex sensory modules, the rigidity-sensing contractile units require many different proteins. It is easy, therefore, to understand how many different mutations or alterations of cells could result in transformation by the loss of a critical sensory machine and why cancer is such a difficult disease to treat. 
Material and Methods

Transfection of siRNA and immunoblotting:
Cells were seeded into a 6-well dish on day 0 and transfected with 25 µM myosin-IIA siRNA (Dharmacon), Tpm 2.1 siRNA (Qiagen) or Tpm 3 siRNA (Dharmacon) using lipofectamine RNAiMAX (Invitrogen) on day 1. Control cells were transfected with scrambled control siRNA (Dharmacon). Transfected cells were lysed in RIPA buffer (Sigma) and proteins extracted were separated by 4-20% SDS-polyacrylamide gel (Bio-rad) and transferred to PVDF membranes (Biorad) at 75V for 2 hours. Membranes incubated with appropriate primary antibodies at 4°C overnight: anti-myosin-IIA (Sigma, dilution 1:1000), anti-Tpm2.1 (Abcam, dilution 1:1000), anti-TM311 (Sigma, dilution 1:1000), anti-TM γ9d (gift from Dr. Peter Gunning, dilution 1:1000), anti-EGFR (CST, dilution 1:1000), anti-HER2 (CST, dilution 1:1000), anti-ROR2 (CST, dilution 1:1000) and anti-α-tubulin (Sigma, dilution 1:3000). The primary antibody binding was processed for ECL detection (Thermo Fisher Scientific) with appropriate HRP-conjugated secondary antibodies (Bio-rad).
Pillar fabrication, video microscopy and force traction measurements:
Molds for making PDMS pillars were fabricated as described before (6) . 0.1g of PDMS (mixed at 10:1, Sylgard 184; Dow Corning) was poured onto the silicon mold and then flipped onto a plasmacleaned glass bottom dish (ibdi). The sample was pressed by an 8g weight, cured at 80°C for 3 hours to reach a Young's modulus of 2MPa and was de-molded while immersed in 99.5%
isopropanol. Pillars were washed with PBS for 5 times before coating with 10 µg/ml fibronectin (Roche) for cell seeding. Time-lapse imaging and traction force measurements were performed as explained before (5).
PAA gel preparation:
Glass bottom dishes (Iwaki) were silanizated using 1.2% 3-methacryloxypropyltrimethoxysilane (Shin-Etsu Chemical, Tokyo, Japan) in 100% Methanol for 1 hour at room temperature. 2.3 kPa Acrylamide gel was prepared as described before (36) . Gel surfaces were treated with sulfo-SANPAN (Thermo Fisher Scientific) and exposed under UV for 5mins before coating with 10 µg/ml fibronectin for cell culture.
Fluorescence microscopy:
Cells were fixed with 4% paraformaldehyde in PBS at 37°C for 15mins and permeabilized with 0.2% TX-100 for 10 mins at room temperature. Samples were blocked with 1% bovine serum albumin (BSA) in PBS for 1h, incubated with primary antibodies for paxillin (BD, 1:200) or Cleaved-Caspase-3 (CST, 1:200) at 4 °C overnight and then incubated with secondary antibodies (Molecular Probes) for 1h at room temperature. Fluorescence images were acquired using a spinning-disc confocal microscope (PerkinElmer Ultraview VoX) attached to an Olympus IX81 inverted microscope body.
Soft agar assay:
The soft agar assay was performed using the Cell Transformation Assays, Standard Soft Agar Kits from Cell Biolabs according to manufacturer's instructions.
Statistical analysis:
Prism (GraphPad Software) and Matlab (Math Works) were used for data analysis and graph plotting. Analyses of significant difference levels were carried out using ANOVA test (for more than 2 experimental groups) or Student's t-test. 
